Peter Pekos
Director/Board Member at CARDIOL THERAPEUTICS INC.
Net worth: 1 M $ as of 30/05/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| David Elsley | M | - | 7 years | |
| Judy Blumstock | F | - |
University of Toronto
Diamond Therapeutics, Inc.
 Diamond Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Diamond Therapeutics, Inc. is a Canadian clinical-stage drug development company founded in 2018 by Judy Blumstock. The company is based in an undisclosed location and is focused on developing safe, FDA, EMA, and Health Canada approved therapies for neuropsychiatric conditions. The company is developing sub-perceptual, non-hallucinogenic, psychedelic-based treatments that hold potential for use across a broad patient cohort, with the goal of maximizing the positive impact better drugs can have on the mental health crisis. Diamond's mission is to develop new and better therapies for mental health conditions by unlocking the promise of psychedelic compounds. | 11 years |
| Christopher Waddick | M | - | 6 years | |
| Guillermo Torre-Amione | M | - | 6 years | |
| Richard Boadway | M | 73 |
Diamond Therapeutics, Inc.
Diamond Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Diamond Therapeutics, Inc. is a Canadian clinical-stage drug development company founded in 2018 by Judy Blumstock. The company is based in an undisclosed location and is focused on developing safe, FDA, EMA, and Health Canada approved therapies for neuropsychiatric conditions. The company is developing sub-perceptual, non-hallucinogenic, psychedelic-based treatments that hold potential for use across a broad patient cohort, with the goal of maximizing the positive impact better drugs can have on the mental health crisis. Diamond's mission is to develop new and better therapies for mental health conditions by unlocking the promise of psychedelic compounds. | - |
| Jennifer Chao | F | 54 | 2 years | |
| Colin Stott | M | 57 | 5 years | |
| Teri Loxam | F | 52 | 2 years | |
| Bernard Lim | M | - | 4 years | |
| Kelly Narine | M | - | 4 years | |
| Blagoja Ristevski | M | - | 9 years | |
| Thomas Moffatt | M | - | 5 years | |
| Trevor Burns | M | - | 7 years | |
| Ana Misra | F | - |
Venturelab
 Venturelab Miscellaneous Commercial ServicesCommercial Services ventureLAB provides business development solutions. Its programs focuses on capital, talent, technology, and customers. The company is headquartered in Markham, Canada. | 13 years |
| Kiernan Lynch | M | 36 | - | |
| William Hilson | M | - |
Diamond Therapeutics, Inc.
Diamond Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Diamond Therapeutics, Inc. is a Canadian clinical-stage drug development company founded in 2018 by Judy Blumstock. The company is based in an undisclosed location and is focused on developing safe, FDA, EMA, and Health Canada approved therapies for neuropsychiatric conditions. The company is developing sub-perceptual, non-hallucinogenic, psychedelic-based treatments that hold potential for use across a broad patient cohort, with the goal of maximizing the positive impact better drugs can have on the mental health crisis. Diamond's mission is to develop new and better therapies for mental health conditions by unlocking the promise of psychedelic compounds. | - |
| Anne Tomalin | F | - | 3 years | |
| Lap-Chee Tsui | M | 73 |
University of Toronto
| 41 years |
| Andrew Hamer | M | 62 | 3 years | |
| Andrew Avi Goldenberg | M | 80 |
University of Toronto
| 42 years |
| Andrea B. Parker | M | - | 5 years | |
| Michael Willner | M | 57 | 3 years | |
| James McCutcheon | M | 61 |
Diamond Therapeutics, Inc.
Diamond Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Diamond Therapeutics, Inc. is a Canadian clinical-stage drug development company founded in 2018 by Judy Blumstock. The company is based in an undisclosed location and is focused on developing safe, FDA, EMA, and Health Canada approved therapies for neuropsychiatric conditions. The company is developing sub-perceptual, non-hallucinogenic, psychedelic-based treatments that hold potential for use across a broad patient cohort, with the goal of maximizing the positive impact better drugs can have on the mental health crisis. Diamond's mission is to develop new and better therapies for mental health conditions by unlocking the promise of psychedelic compounds. | - |
| John Geddes | M | - | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Terrence Lynch | M | 65 | 2 years | |
| Eldon Smith | M | 84 | 4 years | |
| S. Steve Popoff | M | - |
York University
University of Toronto
| 8 years |
| Jon A. Douglas | M | 61 |
York University
University of Toronto
| 6 years |
| Valdis Martinsons | M | - |
University of Toronto
| 7 years |
| Carol Hansell | F | 66 |
University of Toronto
York University
| 4 years |
| Elizabeth M. Nash | F | - |
University of Toronto
| 5 years |
| Emil Dick-Yam Fung | M | - |
York University
University of Toronto
| 7 years |
| Lynda Covello | F | - |
York University
University of Toronto
| 7 years |
| Ronald Daniels | M | 64 |
University of Toronto
| 8 years |
| Davin Andrew Gibbins | M | - |
University of Toronto
| 5 years |
| Andrew Pyle | M | - |
University of Toronto
| 5 years |
| Gerald D. Mintz | M | 71 |
University of Toronto
| 3 years |
| George Brack | M | 62 |
University of Toronto
York University
| 7 years |
| Jeffrey Harley Cole | M | - |
University of Toronto
| 7 years |
| Herman Heryadi Bunjamin | M | 68 |
University of Toronto
| 6 years |
| Terry Kawaja | M | - |
York University
| 4 years |
| Bruno M. Scherzinger | M | - |
University of Toronto
| 5 years |
| Gail Mudie | F | - |
University of Toronto
| 6 years |
| Bill Maslechko | M | 63 |
University of Toronto
| 4 years |
| Hari Sambasivam | M | - |
University of Toronto
| 10 years |
| Michel Fattouche | M | 66 |
University of Toronto
| 5 years |
| Stephanie B. Griffiths | F | - |
University of Toronto
| - |
| Iain Chalmers | M | - | 4 years | |
| Francis Shen | M | 65 |
University of Toronto
| 5 years |
| Deborah Brown | F | - | 3 years | |
| Hamid Mumin | M | - |
University of Toronto
| 4 years |
| Bill Shaw | M | - |
University of Toronto
York University
| 5 years |
| Kin Man Lam | M | 63 |
University of Toronto
| 6 years |
| Paul English | M | - |
University of Toronto
| - |
| Mark F. Wheeler | M | - |
University of Toronto
| 3 years |
| Elaine Ellingham | F | 65 |
University of Toronto
| 4 years |
| Vito Culmone | M | 59 |
University of Toronto
| 4 years |
| Tandjung Sunarto Tan | M | 67 |
University of Toronto
| 4 years |
| Joseph Grech | M | - |
University of Toronto
| 4 years |
| Janet Yale | F | - |
University of Toronto
| 3 years |
| Richard Paul Rogers | M | - |
University of Toronto
| 4 years |
| Chris Ouslis | M | - |
University of Toronto
| 4 years |
| Leo Giovanni Ciccone | M | - |
University of Toronto
| 4 years |
| Anthony Cina | M | 60 |
University of Toronto
| 4 years |
| Graham Symmonds | M | 62 |
University of Toronto
| 4 years |
| Mike Flintoff | M | - |
University of Toronto
| 4 years |
| Wa Yung Cheung | F | 61 |
University of Toronto
| 4 years |
| Debbie McPherson | F | - |
University of Toronto
| 4 years |
| Wendy Ford | F | - |
University of Toronto
| 4 years |
| Chung Wing Cheung | M | 66 |
University of Toronto
| 4 years |
| Elias Vamvakas | M | 65 |
University of Toronto
| 4 years |
| Volkert Bobeldijk | M | - |
University of Toronto
| 4 years |
| Brian Crawford | M | 78 |
University of Toronto
| 4 years |
| Brian T. McGee | M | 63 |
University of Toronto
| 4 years |
| Lynn Jolliffe | F | 72 |
University of Toronto
| 2 years |
| Richard W. Owens | M | - |
University of Toronto
| 4 years |
| John Davison | M | 65 |
University of Toronto
| 6 years |
| Mike Weir | M | - |
University of Toronto
| 4 years |
| James B. C. Doak | M | 68 |
University of Toronto
| 4 years |
| David William Briggs | M | - |
University of Toronto
| 4 years |
| Warren John Stoddart | M | - |
University of Toronto
| 4 years |
| Scott Nirenberski | M | - |
University of Toronto
| 4 years |
| Gary Love | M | - |
University of Toronto
| 4 years |
| Jim McGovern | M | 61 |
University of Toronto
| 4 years |
| David Mark Calnan | M | 68 |
University of Toronto
| 3 years |
| Stephen Wallace Richards | M | - |
University of Toronto
| 4 years |
| Jeffrey Rosenthal | M | 65 |
University of Toronto
| 4 years |
| Michael Calpin | M | - |
University of Toronto
| 4 years |
| Nikolaos Tsimidis | M | 58 |
University of Toronto
| 4 years |
| Peter MacPhail | M | - |
University of Toronto
| 4 years |
| Glenn Kumoi | M | 61 |
University of Toronto
| 4 years |
| P. Martin Petkovich | M | - |
University of Toronto
| 3 years |
| Anna Marks | F | - |
University of Toronto
| 4 years |
| Rocco Cappuccitti | M | - |
University of Toronto
| 4 years |
| Paul Betsis | M | - |
University of Toronto
| 4 years |
| Alexander Horvath | M | - |
University of Toronto
| 4 years |
| Elmer Kim | M | - |
University of Toronto
| 4 years |
| Colin Foster | M | 61 |
University of Toronto
| 4 years |
| Doug Brown | M | - |
University of Toronto
| 4 years |
| Kim Yum Chan | F | 65 |
University of Toronto
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Canada | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Peter Pekos
- Personal Network